1. At a Glance – Blink and You’ll Miss the Profits
Moxsh Overseas Educon Ltd is that ambitious kid in the education bazaar who wants to do everything everywhere all at once—overseas education counselling, medical coaching, non-medical EU placements, B2B tech platforms, and now… primary healthcare clinics. At a current price of ₹81.5 and a market capitalisation of roughly ₹73 crore, the stock has delivered triple-digit returns over the last year, even while the business itself is busy delivering losses with confidence. Latest half-year numbers show sales of ₹2.41 crore with a PAT loss of ₹2.39 crore, which is basically a masterclass in symmetry—but not the good kind. ROE sits at a depressing -5.20%, ROCE at a barely-breathing 1.13%, and debt has climbed to ₹6.41 crore. Yet promoters hold a chunky 62.43%, the chart looks like a Bollywood comeback story, and retail investors are clearly vibing. The big question: is this a misunderstood growth platform… or just a very expensive counselling session for shareholders?
2. Introduction – From MBBS Abroad to OPD Nearby
Founded in 2018, Moxsh Overseas Educon entered the market with a clear pitch: help Indian students chase medical degrees abroad without getting lost in shady agents, fake colleges, or WhatsApp “consultants” with profile photos stolen from Google. That alone was a decent business idea. Over time, Moxsh decided that plain vanilla counselling was too boring, so it added layers—global medical licensing prep, EU non-medical placements, institutional tie-ups, B2B tech platforms, and finally, a rather bold pivot into Edu-Clinics under the brand Studium.
On paper, it sounds visionary. In practice, it sounds like a PowerPoint that kept adding slides because no one said “bas bhai”. The company now operates across seven countries, has multiple brands doing slightly overlapping things, and is trying to monetise aspirations at scale. Unfortunately, FY24 ended in losses, FY25 didn’t magically fix things, and H1 FY26 numbers show that cash is still allergic to staying inside the company.
Still, the market loves a good story, especially when it involves overseas dreams, doctors, and the word “platform”. So let’s calmly unpack what Moxsh actually does, how the numbers look when stripped of marketing gloss, and whether this is early-stage chaos or late-stage confusion. Ready?
3. Business Model – WTF Do They Even Do?
At its core, Moxsh Overseas Educon is an education services aggregator monetising counselling, coaching, and placements.
First pillar: Moksh Academy. This is the bread-and-butter brand focused on medical aspirants—students who want to study MBBS abroad and later clear exams like USMLE. Moxsh earns via counselling fees, commissions from foreign universities, and coaching programs. This is B2C, aspiration-heavy, and volume-driven.
Second pillar: Moksh (Non-Medical EU Placements). Here the company tries to place students in European universities for non-medical courses. Management expects around 100 students, which tells you this is still experimental, not exactly a revenue engine.
Third pillar: B2B Platform – XERA. This is where Moxsh tries to look tech-savvy. Agents from India, Dubai, Qatar, Sri Lanka, and Germany can plug into this platform to process applications. In theory, scalable. In reality, still early-stage.
Fourth pillar: Studium Edu-Clinics. This is the wild card. A mix of counselling centre, digital classroom, and a primary healthcare clinic operated with doctors via franchise agreements. Five company-owned centres, 14
